Literature DB >> 8631002

Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q.

E J Bryan1, R H Watson, M Davis, A Hitchcock, W D Foulkes, I G Campbell.   

Abstract

The detection of loss of heterozygosity, indicative of the presence of a tumor suppressor gene, has been reported to occur frequently on chromosome 22q in human ovarian cancer. In this study, 110 sporadic ovarian tumors were analyzed using 8 polymorphic loci to define a minimum region of loss. Fifty-eight (53%) tumors showed loss of heterozygosity, and of these 6 exhibited partial loss, enabling the identification of two candidate tumor suppressor gene loci. One region, of less than 0.5 cM, is flanked by D22S284 and CYP2D, and a second region lies distal to D22S276. Analysis of loss of heterozygosity with respect to grade and stage suggests that chromosome 22q loss of heterozygosity is of more relevance in tumor progression rather than initiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631002

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma.

Authors:  Chong-Zhi Zhou; Zhi-Hai Peng; Fang Zhang; Guo-Qiang Qiu; Lin He
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

2.  MicroRNA genes and their target 3'-untranslated regions are infrequently somatically mutated in ovarian cancers.

Authors:  Georgina L Ryland; Jennifer L Bearfoot; Maria A Doyle; Samantha E Boyle; David Y H Choong; Simone M Rowley; Richard W Tothill; Kylie L Gorringe; Ian G Campbell
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

3.  A simple consensus approach improves somatic mutation prediction accuracy.

Authors:  David L Goode; Sally M Hunter; Maria A Doyle; Tao Ma; Simone M Rowley; David Choong; Georgina L Ryland; Ian G Campbell
Journal:  Genome Med       Date:  2013-09-30       Impact factor: 11.117

4.  Endometriosis: a new cellular and molecular genetic approach for understanding the pathogenesis and evolutivity.

Authors:  Jean Bouquet De Jolinière; Jean Marc Bernard Ayoubi; Luca Gianaroli; Jean Bernard Dubuisson; Jean Gogusev; Anis Feki
Journal:  Front Surg       Date:  2014-05-27

5.  Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer.

Authors:  Ella R Thompson; Simone M Rowley; Sarah Sawyer; Diana M Eccles; Alison H Trainer; Gillian Mitchell; Paul A James; Ian G Campbell
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

6.  No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer.

Authors:  Ian G Campbell; David Choong; Georgia Chenevix-Trench
Journal:  Breast Cancer Res       Date:  2004-05-14       Impact factor: 6.466

7.  Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors.

Authors:  Georgina L Ryland; Sally M Hunter; Maria A Doyle; Franco Caramia; Jason Li; Simone M Rowley; Michael Christie; Prue E Allan; Andrew N Stephens; David D L Bowtell; Ian G Campbell; Kylie L Gorringe
Journal:  Genome Med       Date:  2015-08-07       Impact factor: 11.117

8.  Loss of heterozygosity: what is it good for?

Authors:  Georgina L Ryland; Maria A Doyle; David Goode; Samantha E Boyle; David Y H Choong; Simone M Rowley; Jason Li; David D L Bowtell; Richard W Tothill; Ian G Campbell; Kylie L Gorringe
Journal:  BMC Med Genomics       Date:  2015-08-01       Impact factor: 3.063

9.  Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes.

Authors:  Sally M Hunter; Michael S Anglesio; Georgina L Ryland; Raghwa Sharma; Yoke-Eng Chiew; Simone M Rowley; Maria A Doyle; Jason Li; C Blake Gilks; Phillip Moss; Prue E Allan; Andrew N Stephens; David G Huntsman; Anna deFazio; David D Bowtell; Kylie L Gorringe; Ian G Campbell
Journal:  Oncotarget       Date:  2015-11-10

10.  Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours.

Authors:  Sally M Hunter; Genevieve V Dall; Maria A Doyle; Richard Lupat; Jason Li; Prue Allan; Simone M Rowley; David Bowtell; Ian G Campbell; Kylie L Gorringe
Journal:  BMC Res Notes       Date:  2020-07-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.